|
|

Title: Herbal based nasal spray
United States Patent: 5,948,414
Inventors: Wiersma; Jack G. (Palm Beach Gardens, FL)
Assignee: Nouveau Technologies, Inc. (Tequesta, FL)
Appl. No.: 047265
Filed: March 24, 1998
Abstract
This invention relates to an improved herbal-based decongestant and
antihistamine nasal spray which includes known constituents in specific
ratios and further includes a saponin. The invention further relates to a
method for treating nasal congestion which results in enhanced
decongestant action and surprising curative effects.
Summary of the Invention
The instant invention is directed to a composition
containing pharmaceutically effective amounts, as said amounts relate to a
nasal spray, of a decongestant, an antihistamine, a preservative, an
aromatic, an emulsifier and an adjuvant; and to a method of use thereof.
In use the composition is diluted to useful concentrations via the
inclusion of water, preferably purified waters such as filtered,
distilled, sterilized and demineralized water. In a preferred embodiment,
demineralized water is utilized. It is known that the mucus film found in
the nasal passageways plays an important part in the bodies defense
mechanism by the constant beating of the cilia, whereby movement of this
film toward the nasopharynx is accomplished, carrying with it trapped
particles to be expectorated or swallowed. This mucus film is rich in
lysozymes and contains glycoproteins and immunoglobulins. Lysozymes are an
important defense against bacteria because they easily digest the lipid
and carbohydrate cell walls of some bacteria and are responsible for the
digestion of the cell walls of pollens and the subsequent release of
antigenic substances. It is with this fact in mind that the inventor has
added a specific amount of a triterpene saponin to the composition being
discussed. By the addition of the triterpene saponin to the composition a
surprising effect has been determined. Inclusion of triterpene saponin
enhances the benefit of the antigenic substances produced by the action of
the lysozymes contained in the mucus film found in the nasal passages.
In a preferred embodiment, the instant invention is defined as a
composition comprising, in combination, effective amounts, as recommended
for a nasal spray environment, of a decongestant commonly referred to as
naphazoline hydrochloride; a preservative commonly referred to as
benzalkonium chloride; an antihistamine commonly referred to as
chlorpheniramine maleate; an aromatic material selected from the group
consisting of menthol, azulen, camphor, eucalyptus oil and mixtures
thereof; an emulsifier, which broadly comprises a chemical dispersing
agent and which is preferably selected from the class of emulsifiers
containing a combination of hydrophobic and hydrophilic substituents,
particularly a combination of glycerol-polyethylene glycol ricinoleate,
fatty acid esters of polyethyleneglycol and polyethylene glycol and
ethoxylated glycerol, and, in a most preferred embodiment comprises an
emulsifying agent available from BASF Aktiengesellschaft and marketed
under the tradename CREMOPHOR EL; an adjuvant commonly referred to as
triterpene saponin that carries the equivalent of a DAB-9 purity rating as
set forth by the German government; and water, preferably demineralized
water.
The composition of the instant invention, utilizing FDA approved
components, is unique in that the individual components, when incorporated
at specific ratios of the total product, offer an improved antihistamine
and decongestant product that delivers the prompt and prolonged desired
effects heretofore not achievable.
Claim 1 of 24 Claims
1. A nasal spray composition comprising in combination pharmaceutically
effective amounts of:
a decongestant selected from the group consisting of naphazoline
hydrochloride, ephedrine, oxymetazoline hydrochloride, phenylephrine
hydrochloride, xylometaxoline hydrochloride and mixtures thereof;
an antihistamine selected from the group consisting of brompheniramine
maleate, chlorpheniramine maleate, doxylamine succinate, phenindamine
tartrate, pheniramine maleate, promethazine maleate, pyrilamine maleate,
thonzylamine hydrochloride, and mixtures thereof;
an aromatic selected from the group consisting of natural oils or extracts
therefrom such as camphor, eucalyptus oil, menthol, azulen and mixtures
thereof;
an emulsifier selected from the class of emulsifiers containing a
combination of hydrophobic and hydrophilic substituents, particularly a
combination of glycerolpolyethylene glycol ricinoleate, fatty acid esters
of polyethyleneglycol and polyethylene glycol and ethoxylated glycerol;
a triterpene saponin adjuvant; and
water.
____________________________________________
If you want to learn more
about this patent, please go directly to the US
Patent and Trademark Office web site to access the full
patent.
|